25 May News FDA Approves Inqovi for Acute Myeloid Leukemia May 25, 2026 By admin 0 comments FRIDAY, May 22, 2026 -- The U.S. Food and Drug Administration has approved Inqovi (decitabine and cedazuridine) plus venetoclax for the...Continue reading
25 May News FDA Grants Accelerated Approval to Hepcludex May 25, 2026 By admin 0 comments FDA Grants Accelerated Approval to Hepcludex (bulevirtide-gmod) Treatment for Chronic Hepatitis Delta Virus (HDV) FOSTER CITY,...Continue reading
25 May News Azithromycin No Benefit for Preschoolers Presenting With Wheeze May 25, 2026 By admin 0 comments FRIDAY, May 22, 2026 -- For preschool-aged children presenting to the emergency department with moderate-to-severe acute wheezing, azit...Continue reading
25 May News Datroway Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates May 25, 2026 By admin 0 comments Tokyo – (May 22, 2026) – Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/NYSE: AZN) Datroway® (datopotamab deruxtecan-dlnk) has b...Continue reading